Literature DB >> 11230177

Primary non-random X inactivation associated with disruption of Xist promoter regulation.

A E Newall1, S Duthie, E Formstone, T Nesterova, M Alexiou, C Johnston, M L Caparros, N Brockdorff.   

Abstract

In this report we demonstrate primary non-random X chromosome inactivation following targeted mutagenesis of a region immediately upstream of XIST promoter P(1). In heterozygous animals there is a preferential inactivation of the targeted X chromosome in 80--90% of cells. The phenotype correlates with inappropriate activation of XIST in a proportion of the mutant XY embryonic stem cells. Strand-specific analysis revealed increased sense transcription initiating upstream of XIST promoter P(1). There was, however, no discernible effect on transcription from the antisense Tsix gene. We demonstrate that the in vitro and in vivo phenotypes are specifically attributable to the presence of a PGKneo cassette at the targeted locus. These findings are discussed in the context of understanding mechanisms of XIST gene regulation in X inactivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230177     DOI: 10.1093/hmg/10.6.581

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  19 in total

1.  An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region.

Authors:  Noopur Thakur; Vijay Kumar Tiwari; Helene Thomassin; Radha Raman Pandey; Meena Kanduri; Anita Göndör; Thierry Grange; Rolf Ohlsson; Chandrasekhar Kanduri
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  The length of the transcript encoded from the Kcnq1ot1 antisense promoter determines the degree of silencing.

Authors:  Chandrasekhar Kanduri; Noopur Thakur; Radha Raman Pandey
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

Review 3.  The silence RNA keeps: cis mechanisms of RNA mediated epigenetic silencing in mammals.

Authors:  Cristina Tufarelli
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

Review 4.  Regulation of X-chromosome inactivation by the X-inactivation centre.

Authors:  Sandrine Augui; Elphège P Nora; Edith Heard
Journal:  Nat Rev Genet       Date:  2011-06       Impact factor: 53.242

5.  RIF1 and KAP1 differentially regulate the choice of inactive versus active X chromosomes.

Authors:  Elin Enervald; Lynn Marie Powell; Lora Boteva; Rossana Foti; Nerea Blanes Ruiz; Gözde Kibar; Agnieszka Piszczek; Fatima Cavaleri; Martin Vingron; Andrea Cerase; Sara B C Buonomo
Journal:  EMBO J       Date:  2021-11-17       Impact factor: 11.598

6.  X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.

Authors:  Juan I Young; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

7.  Identification of regulatory elements flanking human XIST reveals species differences.

Authors:  Samuel C Chang; Carolyn J Brown
Journal:  BMC Mol Biol       Date:  2010-03-08       Impact factor: 2.946

Review 8.  X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?

Authors:  Stéphanie Olivier-Van Stichelen; Lara K Abramowitz; John A Hanover
Journal:  Biochem Biophys Res Commun       Date:  2014-06-21       Impact factor: 3.575

9.  Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.

Authors:  Maaike van Putten; Margriet Hulsker; Courtney Young; Vishna D Nadarajah; Hans Heemskerk; Louise van der Weerd; Peter A C 't Hoen; Gert-Jan B van Ommen; Annemieke M Aartsma-Rus
Journal:  FASEB J       Date:  2013-03-04       Impact factor: 5.191

10.  Skewing X chromosome choice by modulating sense transcription across the Xist locus.

Authors:  Tatyana B Nesterova; Colette M Johnston; Ruth Appanah; Alistair E T Newall; Jonathan Godwin; Maria Alexiou; Neil Brockdorff
Journal:  Genes Dev       Date:  2003-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.